112 related articles for article (PubMed ID: 1720753)
1. Construction of plasmid vectors with a non-antibiotic selection system based on the Escherichia coli thyA+ gene: application to cholera vaccine development.
Morona R; Yeadon J; Considine A; Morona JK; Manning PA
Gene; 1991 Oct; 107(1):139-44. PubMed ID: 1720753
[TBL] [Abstract][Full Text] [Related]
2. [Expression plasmid-host strain using chromosome-plasmid balanced lethal system based on the Escherichia coli thyA].
Huang W; Cao C; Li P; Zhong H; Ma QJ
Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):521-6. PubMed ID: 15969077
[TBL] [Abstract][Full Text] [Related]
3. A Novel Nonantibiotic,
Terrinoni M; Nordqvist SL; Källgård S; Holmgren J; Lebens M
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29222103
[TBL] [Abstract][Full Text] [Related]
4. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
Chen D; Ma Q
Chin J Biotechnol; 1997; 13(1):43-50. PubMed ID: 9376506
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
Viret JF; Cryz SJ; Lang AB; Favre D
Mol Microbiol; 1993 Jan; 7(2):239-52. PubMed ID: 7680409
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101.
Yu F; Qi G; Liu Y; Gao S; Kan B
Mol Biotechnol; 2005 Mar; 29(3):191-6. PubMed ID: 15767696
[TBL] [Abstract][Full Text] [Related]
7. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae.
Ryan ET; Crean TI; Kochi SK; John M; Luciano AA; Killeen KP; Klose KE; Calderwood SB
Infect Immun; 2000 Jan; 68(1):221-6. PubMed ID: 10603391
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.
Manning PA; Heuzenroeder MW; Yeadon J; Leavesley DI; Reeves PR; Rowley D
Infect Immun; 1986 Aug; 53(2):272-7. PubMed ID: 2426198
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase gene from Lactococcus lactis as a genetic marker: an alternative to antibiotic resistance genes.
Ross P; O'Gara F; Condon S
Appl Environ Microbiol; 1990 Jul; 56(7):2164-9. PubMed ID: 2117883
[TBL] [Abstract][Full Text] [Related]
10. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
11. ThyA as a selection marker in construction of food-grade host-vector and integration systems for Streptococcus thermophilus.
Sasaki Y; Ito Y; Sasaki T
Appl Environ Microbiol; 2004 Mar; 70(3):1858-64. PubMed ID: 15006818
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and amplification of the gene for thymidylate synthetase of E. coli.
Hickson ID; Atkinson KE; Emmerson PT
Gene; 1982 Jun; 18(3):257-60. PubMed ID: 6290329
[TBL] [Abstract][Full Text] [Related]
13. Construction of a cloning vector from a naturally occurring plasmid of Salmonella typhimurium.
Roy RK; Murty SS; Chakravorty M
Plasmid; 1995 Sep; 34(2):144-7. PubMed ID: 8559802
[TBL] [Abstract][Full Text] [Related]
14. A transcription terminator in the thymidylate synthase (thyA) structural gene of Escherichia coli and construction of a viable thyA::Kmr deletion.
Bell-Pedersen D; Galloway Salvo JL; Belfort M
J Bacteriol; 1991 Feb; 173(3):1193-200. PubMed ID: 1991715
[TBL] [Abstract][Full Text] [Related]
15. Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement.
Howell EE; Foster PG; Foster LM
J Bacteriol; 1988 Jul; 170(7):3040-5. PubMed ID: 2838456
[TBL] [Abstract][Full Text] [Related]
16. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
[TBL] [Abstract][Full Text] [Related]
17. Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs.
Morona R; Morona JK; Considine A; Hackett JA; van den Bosch L; Beyer L; Attridge SR
Vaccine; 1994 May; 12(6):513-7. PubMed ID: 7913567
[TBL] [Abstract][Full Text] [Related]
18. Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker.
Fu X; Xu JG
Microbiol Immunol; 2000; 44(7):551-6. PubMed ID: 10981827
[TBL] [Abstract][Full Text] [Related]
19. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
20. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
Waldor MK; Tschäpe H; Mekalanos JJ
J Bacteriol; 1996 Jul; 178(14):4157-65. PubMed ID: 8763944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
